Get started
Author

Giuseppe Grimaldi

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
2016 · F. Ciardiello, N. Normanno, et al. · Annals of Oncology · 94
Multiple sclerosis in southern Europe. I: Prevalence in Sicily in 1975.
1979 · G Dean, G Grimaldi, et al. · Journal of Epidemiology & Community Health · 76
PDF
Treatment of pulmonary neuroendocrine tumours: State of the art and future developments
2012 · Cesare Gridelli, Antonio Rossi, et al. · Cancer Treatment Reviews · 69
High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy
2001 · L. M.E. Grimaldi, G. Salemi, et al. · Neurology · 62
A further study on the prevalence of multiple sclerosis in Sicily: Caltanissetta city
2009 · Giovanni Savettieri, Marta Elian, et al. · Acta Neurologica Scandinavica · 48
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial
2018 · Carlo Buonerba, Pietro De Placido, et al. · Frontiers in Pharmacology · 37
PDF
Incidence of fibroblastic sleeve and of catheter-related venous thrombosis in peripherally inserted central catheters: A prospective study on oncological and hematological patients
2020 · Carmela Trezza, Catello Califano, et al. · The Journal of Vascular Access · 31
Weekly Low Dose Epirubicin in Elderly Cancer Patients
1996 · Dario Nicolella, Giuseppe Grimaldi, et al. · Tumori Journal · 19
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
2017 · Michele Orditura, Adriano Gravina, et al. · ESMO Open · 13
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial
2016 · E. Martinelli, C. Cardone, et al. · ESMO Open · 11
PDF
Everolimus as second-line therapy for metastatic renal cell carcinoma: a ‘real-life’ study
2014 · Mimma Rizzo, Gaetano Facchini, et al. · Future Oncology · 10
Nédemax® Mese (Leucoselect®, Lymphaselect®, Bromelain) in the treatment of chronic venous disease: a multicenter, observational study
2019 · Rino Albrigo, Cinzia Andreoni, et al. · Acta Phlebologica · 7
Works count: 12
Citation count: 477
H-index: 10
I10-index: 11
Year
Topic
Type